View in EDS

Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.

Saved in:
Bibliographic Details
Title: Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.
Authors: Gorman DM; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Li XX; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Lee JD; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Fung JN; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Cui CS; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Lee HS; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Rolfe BE; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia., Woodruff TM; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.; Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia., Clark RJ; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.
Source: Journal of medicinal chemistry [J Med Chem] 2021 Nov 25; Vol. 64 (22), pp. 16598-16608. Date of Electronic Publication: 2021 Nov 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1520-4804
DOI:10.1021/acs.jmedchem.1c01174